FFS - Far Field Sensing Test Study in Cardiac Dual Chamber Pacemakers
Primary Purpose
Atrial Fibrillation
Status
Completed
Phase
Phase 4
Locations
Germany
Study Type
Interventional
Intervention
Individualized Programming of PVAB
Nominal PVAB
Sponsored by
About this trial
This is an interventional prevention trial for Atrial Fibrillation
Eligibility Criteria
Inclusion Criteria: Indication for dual chamber pacing Implantation of an Identity DR pacemaker (St. Jude Medical) Bipolar atrial pacing electrode Exclusion Criteria: Heart failure NYHA III and IV Unstable angina pectoris Indication for the implantation of an ICD Cardiac surgery within previous 6 months Cardiac surgery planed for the next 3 months
Sites / Locations
- Deutsches Herzzentrum Muenchen
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Experimental
Arm Label
1
2
Arm Description
Optimization of the postventricular atrial blanking period to avoid far-field R-wave sensing.
Programming of the nominal setting for the post-ventricular atrial blanking period (100 ms)
Outcomes
Primary Outcome Measures
Incidence of inappropriate mode switch due to far field R-wave sensing
Secondary Outcome Measures
Incidence of inappropriate mode switch due to far field R-wave sensing in relation to the lead position
Full Information
NCT ID
NCT00196144
First Posted
September 12, 2005
Last Updated
November 23, 2007
Sponsor
Deutsches Herzzentrum Muenchen
1. Study Identification
Unique Protocol Identification Number
NCT00196144
Brief Title
FFS - Far Field Sensing Test Study in Cardiac Dual Chamber Pacemakers
Official Title
Far Field Sensing Test Study in Patients With Implanted Cardiac Dual Chamber Pacemakers
Study Type
Interventional
2. Study Status
Record Verification Date
November 2007
Overall Recruitment Status
Completed
Study Start Date
July 2002 (undefined)
Primary Completion Date
undefined (undefined)
Study Completion Date
April 2004 (Actual)
3. Sponsor/Collaborators
Name of the Sponsor
Deutsches Herzzentrum Muenchen
4. Oversight
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
The purpose of this study is to evaluate the effect of individual adjustment of the postventricular atrial blanking period in avoiding inappropriate mode switch of dual chamber pacemakers.
Detailed Description
Far-field R-wave sensing (FFS) in the atrial channel of dual chamber pacemakers is a relevant source for inappropriate mode switch from the DDD mode to the DDI or VDI mode. Inappropriate loss of atrioventricular synchrony due to false positive mode switch is hemodynamically disadvantageous, may induce atrial tachyarrhythmias, can lead to pacemaker syndrome, and impairs the reliability of pacemaker Holter data. The aim of the study is to determine whether individual adjustment of the postventricular atrial blanking period (PVAB) based on an additional test is effective in avoiding inappropriate mode switch due to FFS when compared to standard programming of the PVAB
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Atrial Fibrillation
7. Study Design
Primary Purpose
Prevention
Study Phase
Phase 4
Interventional Study Model
Parallel Assignment
Masking
Participant
Allocation
Randomized
Enrollment
207 (Actual)
8. Arms, Groups, and Interventions
Arm Title
1
Arm Type
Experimental
Arm Description
Optimization of the postventricular atrial blanking period to avoid far-field R-wave sensing.
Arm Title
2
Arm Type
Experimental
Arm Description
Programming of the nominal setting for the post-ventricular atrial blanking period (100 ms)
Intervention Type
Device
Intervention Name(s)
Individualized Programming of PVAB
Intervention Description
Performance of a test to detect far-field R-wave sensing
Intervention Type
Device
Intervention Name(s)
Nominal PVAB
Intervention Description
nominal pacemaker settings
Primary Outcome Measure Information:
Title
Incidence of inappropriate mode switch due to far field R-wave sensing
Time Frame
3 months
Secondary Outcome Measure Information:
Title
Incidence of inappropriate mode switch due to far field R-wave sensing in relation to the lead position
Time Frame
3 months
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Indication for dual chamber pacing
Implantation of an Identity DR pacemaker (St. Jude Medical)
Bipolar atrial pacing electrode
Exclusion Criteria:
Heart failure NYHA III and IV
Unstable angina pectoris
Indication for the implantation of an ICD
Cardiac surgery within previous 6 months
Cardiac surgery planed for the next 3 months
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Claus Schmitt, MD
Organizational Affiliation
Deutsches Herzzentrum Muenchen
Official's Role
Study Chair
First Name & Middle Initial & Last Name & Degree
Christof Kolb, MD
Organizational Affiliation
Deutsches Herzzentrum Muenchen
Official's Role
Principal Investigator
Facility Information:
Facility Name
Deutsches Herzzentrum Muenchen
City
Munich
ZIP/Postal Code
80636
Country
Germany
12. IPD Sharing Statement
Citations:
PubMed Identifier
16948743
Citation
Kolb C, Wille B, Maurer D, Schuchert A, Weber R, Schibgilla V, Klein N, Hummer A, Schmitt C, Zrenner B; FFS-Test Study Group. Management of far-field R wave sensing for the avoidance of inappropriate mode switch in dual chamber pacemakers: results of the FFS-test study. J Cardiovasc Electrophysiol. 2006 Sep;17(9):992-7. doi: 10.1111/j.1540-8167.2006.00545.x.
Results Reference
result
Learn more about this trial
FFS - Far Field Sensing Test Study in Cardiac Dual Chamber Pacemakers
We'll reach out to this number within 24 hrs